High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Abstract

It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas (TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life.

Cited by papers we hold 53

• Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers · 2022
  Not checked
• The Independent Association of TSH and Free Triiodothyronine Levels With Lymphocyte Counts Among COVID-19 Patients · 2022
  Not checked
• Interleukin-17, a salivary biomarker for COVID-19 severity. · 2022
  Not checked
• Characterisation and natural progression of SARS-CoV-2 infection in ferrets · 2022
  Not checked
• Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan · 2021
  Not checked
• The treatment of Covid tongue in an isolation unit · 2021
  Not checked
• COVID-19: Characteristics and Therapeutics · 2021
  No notice
• Pediatric COVID-19 presenting as supraglottitis with vocal cord hypomobility · 2021
  Not checked
• Analytical recommendations for SARS-CoV-2 identification by RT-PCR in pediatric patients · 2021
  Not checked
• Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation · 2021
  No notice
• Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability · 2021
  Not checked
• Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect · 2021
  Not checked
• T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression · 2021
  No notice
• Microbiota Modulation of the Gut-Lung Axis in COVID-19 · 2021
  No notice
• SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity · 2021
  No notice
• Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms · 2021
  No notice
• Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools · 2020
  Not checked
• Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019 · 2020
  Not checked
• Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2 · 2020
  Not checked
• Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies · 2020
  No notice

and 33 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.